机器人手术系统市场：依细分市场划分的规模、占有率、法规、偿付、安装基础、到2033年的预测

机器人手术系统目的是提高外科医生的精确度并使困难的手术变得更加容易，回避微创手术（MIS）中仍然存在的局限性。机器人手术系统是由外科医生控制的被动设备，通常由患者侧推车、外科医生控制台和视觉系统组成。

机器人手术系统目的是最大限度地减少微创手术（MIS）的局限性并提高开放性手术的效果。这些系统用于心血管、一般外科、骨科、神经外科、产科、妇科和泌尿科手术。市场的主要驱动因素是人口老化导致外科手术的增加。人口老化导致许多需要手术干预的疾病和病症的风险增加。

本报告深入探讨了全球机器人手术系统市场，包括竞争格局、SWOT 分析、到2033年的市场预测以及区域和国家趋势。

目录

目前市面上的机器人手术系统及竞争状况

• 对主要产业趋势的见解
• 2015年至2033年机器人手术系统各细分市场的市场总收入及市场前景
• 依细分市场划分的手术总数、单位数量、平均售价和市场价值的详细资料

全球、区域与国家见解

• 机器人手术系统市场的SWOT分析
• 机器人手术系统市场的竞争动态洞察与趋势
• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技的监管状况

Robotic Surgical Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.

Robotic Surgical Systems are designed to work around the limitations still present in minimally invasive surgical (MIS) procedures by improving surgeon accuracy and facilitating difficult procedures. Robotic surgical systems are passive devices controlled by a surgeon, and typically consist of a patient side cart, a surgeon console, and a vision system.

Robotic Surgical Systems are designed to minimize the limitations of minimally invasive surgery (MIS), as well as to improve outcomes in open surgical procedures. These systems are utilized for cardiovascular, general surgery, orthopedic, neurosurgery, obstetrics, gynecology, and urological procedures. The primary driver of the market is the increasing number of surgical procedures, propelled by the growing aging population. Aging populations are at a higher risk of developing a host of diseases and conditions necessitating the need for surgical interventions.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Robotic Surgical Systems and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Robotic Surgical Systems market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Robotic Surgical Systems market.
• Competitive dynamics insights and trends provided for Robotic Surgical Systems market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Intuitive Surgical Inc, Stryker Corp, Zimmer Biomet Robotics, Mazor Robotics Ltd., Blue Belt Technologies, Inc., Auris Health Inc, Depuy Synthes Inc, Globus Medical Inc, Medrobotics Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Robotic Surgical Systems market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Robotic Surgical Systems market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Robotic Surgical Systems market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Robotic Surgical Systems market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.